您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > AM095
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
AM095
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
AM095图片
CAS NO:1345614-59-6
规格:98%
分子量:478.47
包装与价格:
包装价格(元)
5mg电议
10mg电议
50mg电议
200mg电议
500mg电议
1g电议

产品介绍
Potent LPA1 receptor antagonist
CAS:1345614-59-6
分子式:C27H23N2NaO5
分子量:478.47
纯度:98%
存储:Store at -20°C

Background:

AM095 is a novel, potent and orally bioavailable antagonist of lysophosphatidic acid type 1 receptor (LPA1) with IC50 values of 0.73 and 0.98 μM for mouse or recombinant human LPA1, respectively [1].


In vitro, AM095 has shown to?inhibit LPA1-induced chemotaxis of both mouse LPA1/CHO cells and human A2058 melanoma cells with IC50 values of 0.78 μM and 0.23μM [1].


In vivo, AM095 could dose-dependently block LPA-induced histamine release with an ED50 value of 8.3 mg/kg in mice. Additionally, AM095 has been revealed to remarkably reduce the BALF collagen and protein with an ED50 value of 10 mg/kg in lungs. AM095 has also shown to decrease both macrophage and lymphocyte infiltration induced by bleomycin in mice [1].


参考文献:
[1] Swaney JS1,?Chapman C,?Correa LD,?Stebbins KJ,?Broadhead AR,?Bain G,?Santini AM,?Darlington J,?King CD,?Baccei CS,?Lee C,?Parr TA,?Roppe JR,?Seiders TJ,?Ziff J,?Prasit P,?Hutchinson JH,?Evans JF,?Lorrain DS. Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist. J Pharmacol Exp Ther.?2011 Mar;336(3):693-700.